Phases of Development at GUD ...1. Get the financing.
2. Build the Canadian base.
3. Build the main artery for ROW.
-----------------
from here, the strategy shifts a little as the future depends on what you get from the past work
-----------------
4. Build the efficiency and the internal workings of the ROW (includes branded generics and the distribution to Central America and the Island)
5. Build the drug partnerships for ROW (this is likely where we are now - starting with Exelon) and I'm hoping that while we bring on additional small partners, we are looking at strengthening the Novartis partnership. Could be Novartis - could be someone else. Keep options open.
6. Look to expand additional arteries of ROW
------------------
The game should look quite obvious now.
Over the next few years, the game will be better recognized by bigger dollars ... imo
: )